The Use of Anti-Diabetic Drugs in Alzheimer’s Disease, New Therapeutic Options and Future Perspective

Journals Menu

Follow SCIRP

ISSN Print: 2157-9423
ISSN Online: 2157-9431
www.scirp.org/journal/pp
E-mail: pp@scirp.org

"The Use of Anti-Diabetic Drugs in Alzheimer’s Disease, New Therapeutic Options and Future Perspective"
written by Osama H. Mohamed Ibrahim, Mariame A. Hassan,
published by Pharmacology & Pharmacy, Vol.9 No.6, 2018

has been cited by the following article(s):

[1]	The Protective Effects of Vanillic Acid and Vanillic Acid‐Coated Silver Nanoparticles (AgNPs) in Streptozotocin‐Induced Diabetic Rats
	Journal of Diabetes Research, 2024

[2]	The Antioxidant and Antidiabetic Activity of Vanillic Acid and Vanillic Acid-Coated Silver Nanoparticles in Streptozotocin-Induced Diabetic Male Rats
	2023

[3]	Alzheimer's disease and type 2 diabetes mellitus: Pathophysiologic and pharmacotherapeutics links
	2021

[4]	Global dynamics for a model of amyloid fibril formation in pancreatic islet beta cells subjected to a therapy
	2020

[1]	The Protective Effects of Vanillic Acid and Vanillic Acid‐Coated Silver Nanoparticles (AgNPs) in Streptozotocin‐Induced Diabetic Rats Journal of Diabetes Research, 2024 DOI:10.1155/2024/4873544

[2]	Alzheimer’s disease and type 2 diabetes mellitus: Pathophysiologic and pharmacotherapeutics links World Journal of Diabetes, 2021 DOI:10.4239/wjd.v12.i6.745

[3]	Global dynamics for a model of amyloid fibril formation in pancreatic islet beta cells subjected to a therapy Journal of Biological Dynamics, 2020 DOI:10.1080/17513758.2020.1736655

Follow SCIRP

Free SCIRP Newsletters

Add your e-mail address to receive free newsletters from SCIRP.

Top